Article
Washington Post
(2020)
The Food and Drug Administration said Tuesday any covid-19 vaccine, to be approved, will have to prevent disease or decrease its severity in at least 50 percent of the people who are vaccinated.
FoundryBase
updated about 15 hours ago
Comments
Related Chunks
Related chunks with this resource
FDA Vaccine approval for COVID19 Coronavirus
RELATED RESOURCES
with chunks in common
2020
Why a coronavirus vaccine could take way longer than a year — National Geographic
Saved by: FoundryBase
used in 3 chunks
MORE RELATED CONTENT
with shared categories
2021
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
Saved by: FoundryBase
used in 1 chunk
2021
Personalized Skin Cancer Vaccine Shows Promise in New Trial Results
Saved by: FoundryBase
used in 4 chunks
2020
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Saved by: FoundryBase
used in 2 chunks
2020
Why Oxford’s positive COVID vaccine results are puzzling scientists
Saved by: FoundryBase
used in 1 chunk
2020
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
Saved by: FoundryBase
used in 1 chunk
2020
Dozens of COVID-19 vaccines are in development. Here are the ones to follow - National Geographic
Saved by: FoundryBase
used in 2 chunks
2020
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug
Saved by: FoundryBase
used in 1 chunk
2020
Nature: The race to make COVID antibody therapies cheaper and more potent (Oct. 2020)
Saved by: FoundryBase
used in 2 chunks
2020
Remdesivir has ‘little or no effect’ in reducing coronavirus deaths, WHO says
Saved by: FoundryBase
used in 1 chunk
2020
U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns
Saved by: FoundryBase
used in 1 chunk
No comments yet. Be the first to comment!